Baricitinib vs Rabeprazole

Baricitinib vs Rabeprazole: Overview

This comparison examines the pharmacological differences between Baricitinib and Rabeprazole.

Mechanism of Action

Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics

Half-life: Baricitinib — 12 hours; Rabeprazole — 1-2 hours.

Chemical Properties

Molecular Formula: Baricitinib — C16H17N7O2S; Rabeprazole — C18H21N3O3S.

Molecular Weight: Baricitinib — 371.4170 g/mol; Rabeprazole — 359.4440 g/mol.

Type: Baricitinib — Small molecule; Rabeprazole — Small molecule.